Literature DB >> 16190812

Initial validation of the SLEEP-50 questionnaire.

Victor I Spoormaker1, Ingrid Verbeek, Jan van den Bout, Ed C Klip.   

Abstract

Initial psychometric properties of the SLEEP-50 questionnaire, designed to detect sleep disorders as listed in the Diagnostic and Statistical Manual of Mental Disorders (4th ed., Text Revision), were examined. The sample consisted of 377 college students, 246 sleep patients, 32 nightmare sufferers, and 44 healthy volunteers. The internal consistency was high (Cronbach's alpha = .85); test-retest correlations fell between .65 and .89. Principal component analysis with a direct oblimin rotation revealed a factor structure that closely matched the designed structure. Sensitivity and specificity scores were promising for all sleep disorders; the agreement between all clinical diagnoses and SLEEP-50-classifications was substantial (kappa = .77). These initial findings indicate that the SLEEP-50 seems able to detect a variety of sleep disorders. The SLEEP-50 can aid in screening for common sleep disorders in the general population.

Entities:  

Mesh:

Year:  2005        PMID: 16190812     DOI: 10.1207/s15402010bsm0304_4

Source DB:  PubMed          Journal:  Behav Sleep Med        ISSN: 1540-2002            Impact factor:   2.964


  52 in total

1.  Lack of Resilience Is Related to Stress-Related Sleep Reactivity, Hyperarousal, and Emotion Dysregulation in Insomnia Disorder.

Authors:  Laura Palagini; Umberto Moretto; Martina Novi; Isabella Masci; Danila Caruso; Christopher L Drake; Dieter Riemann
Journal:  J Clin Sleep Med       Date:  2018-05-15       Impact factor: 4.062

Review 2.  A systematic review of cognitive-behavioral treatment for nightmares: toward a well-established treatment.

Authors:  Jaap Lancee; Victor I Spoormaker; Barry Krakow; Jan van den Bout
Journal:  J Clin Sleep Med       Date:  2008-10-15       Impact factor: 4.062

3.  Sleep-Related Attentional Bias for Faces Depicting Tiredness in Insomnia: Evidence From an Eye-Tracking Study.

Authors:  Umair Akram; Anna Robson; Antonia Ypsilanti
Journal:  J Clin Sleep Med       Date:  2018-06-15       Impact factor: 4.062

4.  Position Paper for the Treatment of Nightmare Disorder in Adults: An American Academy of Sleep Medicine Position Paper.

Authors:  Timothy I Morgenthaler; Sanford Auerbach; Kenneth R Casey; David Kristo; Rama Maganti; Kannan Ramar; Rochelle Zak; Rebecca Kartje
Journal:  J Clin Sleep Med       Date:  2018-06-15       Impact factor: 4.062

5.  Comparative meta-analysis of prazosin and imagery rehearsal therapy for nightmare frequency, sleep quality, and posttraumatic stress.

Authors:  Gilbert Seda; Maria M Sanchez-Ortuno; Carolyn H Welsh; Ann C Halbower; Jack D Edinger
Journal:  J Clin Sleep Med       Date:  2015-01-15       Impact factor: 4.062

6.  Do Energy Drink Consumers Study More?

Authors:  Leslie W Oglesby; Kristina A Amrani; Christopher J Wynveen; Andrew R Gallucci
Journal:  J Community Health       Date:  2018-02

7.  Development and initial validation of the Iowa Sleep Disturbances Inventory.

Authors:  Erin Koffel; David Watson
Journal:  Assessment       Date:  2010-05-19

8.  Relationship between sleep disturbance and depression, anxiety, and functioning in college students.

Authors:  Maren Nyer; Amy Farabaugh; Kiki Fehling; David Soskin; Daphne Holt; George I Papakostas; Paola Pedrelli; Maurizio Fava; Angela Pisoni; Ottavio Vitolo; David Mischoulon
Journal:  Depress Anxiety       Date:  2013-05-16       Impact factor: 6.505

9.  Guided Online or Face-to-Face Cognitive Behavioral Treatment for Insomnia: A Randomized Wait-List Controlled Trial.

Authors:  Jaap Lancee; Annemieke van Straten; Nexhmedin Morina; Viktor Kaldo; Jan H Kamphuis
Journal:  Sleep       Date:  2016-01-01       Impact factor: 5.849

10.  Evaluation of the reliability and validity of the Medical Outcomes Study sleep scale in patients with painful diabetic peripheral neuropathy during an international clinical trial.

Authors:  Muriel Viala-Danten; Susan Martin; Isabelle Guillemin; Ron D Hays
Journal:  Health Qual Life Outcomes       Date:  2008-12-17       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.